THE ACTN3 GENE ENCODES the protein ␣-actinin-3. ␣-Actinin-3 is an actin-binding protein that is structurally related to dystrophin (6) . In humans, two genes encode for skeletal muscle ␣-actinins: ACTN2, which is expressed in all skeletal muscle fibers, vs. ACTN3, whose expression is limited to fast-twitch muscle fibers (100% of type IIb/x fibers and 50% of type IIa fibers; Refs. 16, 17) . ␣-Actinins are important structural components of the Z-membrane (1) where they form the crosslink between the thin actin filaments. They have a static function in maintaining ordered myofibrillar arrays and a regulatory function in coordinating myofiber contraction (13) . Interestingly, in European Caucasian populations ϳ18% of the individuals are fully ␣-actinin-3 protein deficient due to homozygosity for a premature stopcodon polymorphism in the ACTN3 gene (Chrom 11. pos. 66084671, C3 T, R577X, rs1815739). However, this deficiency does not result in a disease phenotype or muscular functional impairment (10, 11, 17) . Still, a number of studies have provided data to indicate that there is a positive association between the presence of the R allele and the capacity to perform high power muscle contractions (14, 15, 24) . On the other hand, the X allele might predispose for better endurance exercise performance (14, 15, 24) . Accordingly, Yang et al. (24) found in a sample of white elite athletes a higher frequency of the 577R allele in both male and female sprinters, while elite endurance athletes exhibited a slightly higher frequency of the XX genotype.
␣-Actinins interact with themselves, structural proteins of the contractile machinery, metabolic enzymes, and signaling proteins (reviewed in Ref. 10) , among them are also members of the Z-line localized calsarcin family (8) . These bind to calcineurin, a Ca 2ϩ -and calmodulin-dependent protein phosphatase, which is a signaling protein and is hypothesized to play a role in the determination of muscle fiber type and muscle hypertrophy (10) , although it does not seem to be implicated in muscle fiber growth in regenerating muscle (19) . Semsarian et al. (20) showed that in reaction to intracellular calcium mobilization, calcineurin is activated. The latter in turn causes a nuclear translocation of the transcription factor nFATc1. In rats, the activation of calcineurin mobilizes satellite cells and causes a switch to a more glycolytic metabolism (20) . On the contrary, Chin et al. (2) reported that the activation of calcineurin selectively up-regulates slow-fiber-specific gene promoters.
Based on genetic epidemiological studies, about half of the variability in fiber type distribution in human muscles is determined by genetic factors (21) . Through its interaction with calcineurin, polymorphisms in the ACTN3 gene could conceivably contribute to heritability of fiber type distribution. The force-generating capacity of type II muscle fibers at high velocity, the speed of movements, and the capacity to adapt to training are all strongly genetically influenced (24) . The contribution of genetic factors in strength measures in part varies according to the angle, to the contraction type, and to some extent the contraction velocity (23) . Contractile property differences according to the presence/absence of ␣-actinin-3 in sarcomeres of fast-type muscle fibers might also contribute to individual differences in power output.
Currently, not much is known about the effect of the ␣-actinin-2/3 protein content in the muscle. North and Beggs (16) observed in 1996 that the ␣-actinin-2/3 protein content is fiber type dependent. They show that while ␣-actinin-2 is found in all skeletal fibers, ␣-actinin-3 is present in only a subset of type II fibers (all type IIb fibers and 50% of the type IIa fibers), although no numeric information was reported previously (16).
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This issue raises the question whether the content of these proteins differs between individuals, and if so, whether this difference can explain variation in performance.
The primary purpose of this study was to investigate the relationship between the ACTN3 (R577X) genotype and muscle fiber type distribution in humans on the one hand and the capacity of force generation of the muscle fibers (at different velocities) on the other hand. The secondary aim was to investigate the relationship between fiber type specific ␣-actinin-2 and -3 protein levels and skeletal muscle performance.
Because of the exclusive prevalence of ␣-actinin-3 in fast glycolytic (type II) muscle fibers and the interaction between the ␣-actinins and calcineurin (with its likely function in fiber type determination), we proposed the following hypotheses. 1) Subjects with ␣-actinin-3 deficiency have lower baseline muscle power than subjects with ␣-actinin-3, and this difference in dynamic strength becomes more obvious with increased velocity of contraction; 2) ACTN3 is essential for the differentiation and structural traits of muscle fibers and explains part of the inter-individual differences in fiber type distribution; and 3) the observed differences in power output can at least in part be explained by a difference in ␣-actinin-2/3 protein content.
MATERIALS AND METHODS

Subjects
Ninety healthy young males (age: 21.7 Ϯ 2.3 y; body wt: 73.3 Ϯ 8.6 kg) gave written consent to participate after being fully informed of the study protocol and procedures. The Ethics Committee of the Faculty of Medicine of Katholieke Universiteit Leuven approved the study protocol. All experiments were conducted in conformity with the principles of the declaration of Helsinki. The subjects were recruited by announcements among the local student population. Inclusion criteria on admission were male, ages 18 -30 y, and in good health. Exclusion criteria were acute or chronic disease, consistent intake of medication or nutrition supplements of any kind during a period of 6 mo before the study, any medical condition that might contra-indicate high-intensity exercise, and a prehistory of consistent resistance training in a period of 12 mo before the study.
Study Protocol
The study was performed in two phases. In phase I, the relationship between the ACTN3 (R577X) polymorphism and muscle strength was studied in the total group (n ϭ 90) of subjects. In phase II, a subgroup was used to compare muscle fiber type distribution and muscle strength between RR (n ϭ 22) and XX (n ϭ 22) ACTN3 homozygotes. Furthermore, in the latter subgroup muscle ␣-actinin-2/3 protein content was also determined.
In phase I, subjects reported twice to the research center within a 3-wk period. In the first session a blood sample was taken from an antecubital vein to be used for DNA extraction and SNP genotyping (RT-PCR, Applied Biosystems). In the second session, the subjects underwent a series of anthropometric measurements. Thigh circumference (TC) and skinfold (TS) measured at half the distance from groin to patella was used to estimate m. quadriceps cross sectional area (CSA), using the following equation: CSAϭ (2.52*TC) Ϫ (1.25*TS) Ϫ 45.13 (9) . Percentage body fat (%), fat mass (kg), and fat free mass (kg) was assessed by a Bio-electric Impedance technique (Biodynamics, Model 310e, Bodycomposition Analyzer, Seattle, WA).
After a short warm-up session on a cycle ergometer, static and dynamic torques of the knee-extensor muscles were measured on a self-constructed computerized active isokinetic dynamometer (servomotor SEW Eurodrive CM90, Bruchsol, Germany). Subjects pushed against a lever arm, and the exerted torque was directly measured using a calibrated torque transducer (type 1605, Lebow Products, Troy, MI, 0.05% accuracy level) mounted in the axis of the system, which was aligned to the axis of the knee joint.
After the subject was positioned in the backward inclined chair (30°) and alignment of the knee was controlled, fixation was applied to upper body and upper leg, and the lower leg was fixed to the lever arm at the level of the ankle. First, subjects were allowed to get familiarized with the testing device by applying submaximal efforts on one static, five repetitions of dynamic extension movements at different speeds (100°/s and 400°/s) as well as one eccentric contraction (20 s rest between contractions). The start of each contraction was indicated by an audible and vibrating signal of the lever arm, and after reaching the end position, the leg was passively returned to the starting position. After familiarization, the exerted torques during maximal voluntary contractions were measured. First, the average of two maximal isometric extensions (5 s) at 45°knee flexion was taken as static torque. Dynamic torques at 100, 200, 300, and 400°/s were defined as the registered torque (at 45°) during one extension movement (from 85°to 5°knee angle, with 0°as extended leg position) at each speed. Finally, eccentric torque was measured during a single maximal knee extension contraction, while knee flexion was forced by the dynamometer at an angular velocity of 100°/s. About 15% of subjects were unable to perform qualitatively correct extensions at 400°/s (with very low torque values), and we therefore chose to exclude this variable from the analyses.
Finally, the total amount of physical activity was assessed by questionnaire (number of h/wk); furthermore, the type of sports activities and recreational/competitive level was registered.
Phase I of the study yielded 22 XX carriers, who were ("ranked") pair-matched by 22 subjects with the RR genotype to obtain 2 homozygote groups (XX vs. RR) with identical distributions for maximal isometric muscle strength and fat free mass. In case several subjects were a candidate match for a subject homozygote for the X allele, a random selection was made. Subjects reported to the laboratory in the morning after an overnight fast. A muscle biopsy was taken from the right vastus lateralis muscle under local anaesthetic (2-3 ml lidocaine) using a Bergström type needle through a 5 mm incision in the skin. After being freed from any visible nonmuscle material, part of the muscle sample was immediately frozen in liquid nitrogen, and the remaining part was mounted in embedding medium (Tissue-Tek, Sakura FineTek, Zoeterwoude, The Netherlands) cooled in isopentane. Samples were stored at Ϫ80°C until they were analyzed for fiber type distribution and ␣-actinin-2/3 protein content at a later date.
Analyses of Blood and Muscle Samples
SNP genotyping. DNA was extracted using the Chemagic DNA Blood Kit on an automated Chemagic Magnetic Separation Module I (Chemagen, Baesweiler, Germany) and a Multiprobe I (PerkinElmer, Waltham, MA) robotic station.
Genotyping was performed using a TaqMan SNP genotyping assay (Applied Biosystems), containing a 20ϫ mix of unlabeled PCR forward and reverse primers as well as a VIC and FAM labeled allele discrimination probe. The Assay ID was C__590093_1. Real-time qPCR was carried out in a 20 l reaction mixture with 5 l cDNA, 4 l RNase-free water, 1 l of 20ϫ TaqMan SNP genotyping assay mix, and 10 l of the 2ϫ Taqman universal PCR master mix (Applied Biosystems). Amplification and detection were performed using the ABI PRISM 7300 sequence detection system (Applied Biosystems). Thermal cycling conditions were 10 min at 95°C followed by 40 two-step cycles, including 15s denaturation at 92°C and 60 s annealing/extension at 60°C. All reactions were set up manually, and allele calling was done using SDS 1.3 software.
Muscle histochemistry. Serial sections (4 m) from biopsy samples were collected on uncoated glass slides. Briefly, cryosections were fixed for 10 min in 4% paraformaldehyde in PBS. Slides were rinsed for 2 ϫ 5 min with wash buffer (0.5% BSA in PBS), treated with 10 mm NH4Cl, and washed again (2 ϫ 5 min). Slides were prehybridized in 1% BSA in PBS for 30 min. Sections were then incubated overnight at 4°C with the primary antibodies. The incubation was followed by 3 ϫ 5 min washes with wash buffer, after which the appropriate conjugated antibodies were added. Finally, the sections were washed again (3 ϫ 5 min in wash buffer) and coverslips were mounted with fluorescent mounting medium (DakoCytomation, Carpinteria, CA). For muscle fiber typing we used primary antibodies directed against human myosin heavy chain I and IIa (A4.840 and N2.261 supernatant from Developmental Studies Hybridoma Bank at the University of Iowa, Iowa City, IA). The primary antibodies against ␣-actinin-2 and ␣-actinin-3 were sera and affinity purified rabbit polyclonal antibodies raised against amino-terminal peptides, rabbit anti-␣-actinin-2 rod raised against a peptide from the central rod domain, and monoclonal mouse anti-merosin M-chain (16) . Fiber type specific stainings for ␣-actinin-2 and ␣-actinin-3 protein content were performed in separate experiments. Pilot experiments revealed no cross-reactions between different primary and secondary antibodies.
The secondary antibodies for fiber typing were FITC anti-mouse IgM (Southern Biotechnology Associates, Birmingham, AL) and Alexa Fluor 350 anti-mouse IgG1 (Molecular Probes, Leiden, the Netherlands) for type I and type IIa fibers, respectively, and anti-rabbit IgG (Abcam, Acris, Germany) for ␣-actinin-2/3. Slides were examined using a Nikon E1000 fluorescence microscope (Nikon, Boerhavedorp, Germany) equipped with a digital camera. Epifluorescence signal was recorded using a FITC, DAPI, and Texas red filter for type I muscle fibers, type IIa muscle fibers, and ␣-actinin-2/3 protein content, respectively, using standardized camera and microscope settings. Captured images (ϫ20 magnification) were processed and analyzed using Lucia G software (LIM, Prague, Czech Republic). Fibers, negatively stained for type I and type IIa, were qualified as type IIx fibers. To eliminate inter-assay variation, samples aimed for mutual comparison were consistently included in the same assay. Background correction was performed by adding negative control samples in each assay.
Forty-three muscle samples were included in the fiber typing analysis. The number of fibers analyzed per sample was 170 Ϯ 11. The intra-assay coefficient of variation for fiber type proportions and surface areas was 5%.
Statistical Analysis
The statistical analyses were done with SAS 9.1 and Statistica 6 software. An ANOVA was performed to evaluate an association effect between the strength phenotypes and the three genotype groups to investigate a possible co-dominant effect. An estimation of the crosssectional area of the quadriceps was used as a covariate in an ANCOVA analysis. To determine possible dominant allele effects, independent sample t-tests were performed (have X allele vs. have no X allele; have R allele vs. have no R allele). To test for a possible contraction-velocity interaction by different ACTN3 genotype groups, a repeated measures ANOVA was applied to raw and relative torque values at different contraction speeds.
Student's t-tests were also used to determine differences between the two selected genotype groups (RR vs. XX, n ϭ 43) in the fiber typing analyses. Pearson (or Spearman) correlations were used to study correlations between staining values for ␣-actinin-2/3 fiberspecific protein content and performance or fiber composition phenotypes. Multiple regression analysis was added to implement the cross sectional area of the quadriceps and fiber type proportions as covariate factors. A probability level (P) Ͻ0.05 was considered statistically significant. All data are expressed as means Ϯ SE.
RESULTS
Prevalence of ACTN3 R577X Polymorphism and Body Composition
The proportion of XX, RX and RR genotypes in the study sample was 0.24, 0.44, and 0.31, respectively. These frequencies are in Hardy-Weinberg equilibrium (Chi 2 value ϭ 0.95; P ϭ 0.33). The allele frequencies are 0.47 and 0.53 for the X allele and R allele, respectively. Body composition characteristics as well as estimated quadriceps muscle cross-sectional area were similar between the three genotypes ( Table 1) .
Muscle Fiber Type Distribution
Muscle fiber type distribution was measured in biopsy samples obtained from m. vastus lateralis ( Table 2 ). On average the relative fraction of type I, IIa, and IIx fibers was 52, 36, and 12%, respectively, in the total group. Genotype-specific differences were found for the percentage number of type IIx fibers, which was ϳ5% higher in the RR than in XX genotype group (P ϭ 0.04). Given similar average surface area per type IIx fiber, the relative muscle surface area covered by type IIx fibers was also slightly greater in the RR than in the XX genotype group (P ϭ 0.03). There were no significant differences between the genotype groups for either type I or type IIa fiber number or surface area.
␣-Actinins-2/3 Protein Content
Muscle ␣-actinin-2/3 protein content was determined using immunohistochemical assays (see Fig. 1 ). Staining intensity for ␣-actinin-3 protein in type II fibers on average was 80% higher in RR than in XX, which confirms the identification of the polymorphism (P Ͻ 0.001; data not shown). Staining intensity was similar between type I fibers in RR and any fiber type in XX, which indicates the lack of expression of ␣-actinin-3 protein in type I fibers (P ϭ 0.72; data not shown). The expression of ␣-actinin-3 protein content was compared between type IIa and type IIx fibers in RR subjects exhibiting a sufficient number (Ͼ10) of type IIx fibers in the muscle sections (n ϭ 11; Fig. 2 ). Staining intensity for ␣-actinin-3 protein content largely varied among the different subjects. However, compared with type IIa fibers, ␣-actinin-3 average red staining in type IIx fibers on average was ϳ17% higher (P ϭ 0.04), and this difference was consistent in all but one individual. Average red staining for ␣-actinin-2 protein content was similar between the two genotype groups (data not shown). Mean Ϯ SE are given. Body composition data are from a subgroup of the total sample (n ϭ 90) (XX: n ϭ 19; RX: n ϭ 40; RR: n ϭ 26).
Muscle Strength
Muscle strength was measured as torque production during maximal static and dynamic knee extensions on an isokinetic dynamometer. As shown in Table 3 absolute torque production was similar among the three genotype groups for either static, dynamic concentric, or eccentric contractions. However, dynamic torque production expressed relative to maximal static torque was different among genotypes for the highest contraction speed. At 300°/s, the RR genotype group showed higher relative knee extension torques than the XX group (P ϭ 0.04; total study group, n ϭ 90). As shown in Fig. 3 for the XX and RR groups, following the strength-velocity relationship, relative torque production decreased as contraction velocity increased. However, this decrease was greater in the XX than in the RR group (genotype by velocity interaction: P ϭ 0.06). Similar results were found when estimated quadriceps crosssectional area, body mas index, or weight was included as a covariate.
Within the RR genotype, there was no correlation between muscle ␣-actinin-3 staining intensity and torque output during high velocity (300°/sec) muscle contractions, even after correction for differences in fiber type distribution in multiple regression analysis.
DISCUSSION
The ACTN3 (R577X) polymorphism causes a complete loss of the ␣-actinin-3 protein in XX homozygotes. About 18 percent of European-ancestry populations are ACTN3 deficient, with no obvious related pathology. The polymorphism has been associated with elite athletic performance; the R allele was more common in sprint and power athletes, while the X allele was more frequent in endurance athletes (10, 11, 14, 15, 24) . Through an interaction with the signaling protein calcineurin, Yang et al. (24) proposed that ␣-actinin-3 might promote the formation of fast twitch fibers.
Here, we tested whether the R577X genotype is associated with baseline muscle strength (dynamic torque), although more specifically the association of this polymorphism with fiber type proportions and characteristics in healthy young men. We also documented fiber type specific ␣-actinin-2/3 protein contents. We took blood samples from 90 men to determine their R577X genotype. These subjects performed several strength measurements at different velocities on a computerised isokinetic dynamometer. From 44 of these subjects (22XX and 22RR carriers), a muscle biopsy was taken for the analysis of fiber type proportions and fiber type specific ␣-actinin-2/3 protein content using immunohistochemical assays.
The relative allele frequency of the 577X allele for our study population was 0.47. This is similar to the frequencies previously reported (3, 13, 14, 24) . Our population frequency for XX homozygotes was 24%, which is slightly higher than the 18% found for Europeans by Yang et al. (24) . This may be due to the specific characteristics of our research population, which consisted mainly of physically active young men (18 -29 y).
We found no association between the ACTN3 genotype and anthropometric or body composition characteristics. These findings are similar to the study of Moran et al. (14) .
XX homozygotes showed significantly less (relative) dynamic muscle power than homozygotes for the wild-type allele (total group and subgroup analysis). In the total group analysis, heterozygotes were intermediate between both homozygotes for most of the quadriceps torque values, indicating a co-dominant gene action. These findings expand on earlier studies that mostly used a case-control approach (15, 25) including elite athletes. Our findings show an additive effect of each R allele to enhance power in healthy nonathlete young men (18 -29 y). Fig. 1 . Immunohistochemical determination of fiber type specific ␣-actinin-3 protein content. This figure shows the fiber type specific staining of ␣-actinin-3 in an RR-carrier subject. The bright blue fibers (A) correspond to type IIa fibers, which also contain the ␣-actinin-3 (bright red staining in B). There is no ␣-actinin-3 in the fibers staining green (type I fibers). The darker blue fibers (type IIx fibers) show relatively more ␣-actinin-3 protein content than the type IIa fibers in this subject.
Other research groups were not able to detect a significant increased muscular strength/power in the untrained state (3, 4) ; however, location (elbow joint), sample ethnicity, and ages were different from the present study.
The major aim of our study was to investigate the role of the ACTN3 (R577X) polymorphism in the determination of fiber type characteristics. We hypothesized that the associations between the ACTN3 (R577X) polymorphism and fast-velocity isokinetic torque could be explained by increased type II muscle fiber differentiation (in RR carriers) and therefore the force delivering capacity of the type II muscle fibers in dynamic (ballistic) movements.
This role of ACTN3 could be through a binding of ␣-actinin-3 with calsarcins that interact with the signaling protein calcineurin to promote the formation of fast twitch fibers (24) .
Calcineurin, a serine-threonine phosphatase activated by Ca 2ϩ -calmodulin, participates in signaling pathways important for gene regulation and biological responses to external stimuli in many organisms and in many types of cells (5, 18) . Chin et al. (2) showed that a signaling pathway that involves calcineurin controls fiber type specific gene expression in skeletal muscles. They identified a molecular mechanism by which different patterns of motor nerve activity selectively promote changes in gene expression to establish the specialized characteristics of slow and fast myofibers (2). Semsarian et al. (20) concluded that calcineurin promotes a switch to a more glycolytic metabolism. In IGF-1 injected rats, activated calcineurin mobilized satellite cells and increased activity of glycolytical enzymes and the end product of the glycolytical metabolism (lactate) (20) .
However, contrary findings are described in the study of Swoap et al. (22) , where they show that active calcineurin is not sufficient to differentially regulate fiber type specific gene expression in whole muscle or in cell culture. Furthermore, Serrano et al. (19) state that calcineurin activity in muscle fibers is required for the induction and the maintenance of the slow muscle gene program and the repression of the fast MyHC-IIx genes. Contrary to the findings of Serrano et al., Michel et al. (12) conclude that calcineurin signaling primarily leads to an adaptation towards a more metabolically efficient phenotype in response to increased muscle usage. Hence, calcineurin is more than a signaling agent for exclusive maintenance of slow type I fiber profiles in response to 'slow/chronic' patterns of nerve activation (12) . Dunn et al. (7) also present a more differentiated role for calcineurin than the sole maintenance of the slow gene program. They state that calcineurin signaling increases in all fiber types with increased nerve-mediated activity. Highly relevant to the findings in this study, most reactivity was found in the less active (IIx) fibers. The authors hypothesize that the transcription of proteins is only increased when activation is above the "native levels" threshold. Cells that already have a high calcineurin activity (type I fibers) become less sensitive for relatively small amounts of increased nerve activity (7) .
In this study, we show a possible role of the ACTN3 gene in the determination of fiber type distribution. We found a positive association between the ACTN3 RR genotype and the amount and fiber surface of fast, glycolytic fibers (IIx) in terms of percentage (P Ͻ 0.05). These data are in agreement with the hypothesis of Yang et al. (24) that ␣-actinin-3 promotes the formation of fast-twitch fibers. These findings suggest that the mechanism, by which the ACTN3 (R577X) polymorphism has its effect on muscle power, might rely, at least in part, on the regulation of fiber type proportions. However, these findings do not exclude that other signaling pathways and interactions with metabolic enzymes also play a role in the ␣-actinin-3 specific effects on the regulation of muscle fiber type distribution in humans (10) .
Finally, we hypothesized that the differences found in dynamic muscle torque might in part rely on a different amount of ␣-actinin-3 protein in the fast muscle fibers in the homozy- gotes for the R allele. We were unable to confirm this hypothesis. We found no correlation between the amount of ␣-actinin-3 staining in the fast fibers and the muscle performance at high velocity. However, for the speed at 100 and 200°/s a trend towards a positive correlation was observed for both ␣-actinin-3 red staining in type IIa and type IIx fibers. Variability within the RR group for high-velocity contractions is probably related to many more genetic and nongenetic factors for which ␣-actinin-3 protein variability would be only one contributing factor. Probably the relatively small sample size of subjects in the RR group with ␣-actinin-3 protein level information and limited effect size of the ␣-actinin-3 protein level do not warrant definite conclusions.
North and Beggs (16) included unpublished observations concerning the partition of ␣-actinin-3 among type II fibers. They observed that the protein is present in all the type IIb fibers and 50% of the type IIa fibers. In our study, population of healthy young men, ␣-actinin-3 was present in all type IIa fibers of RR carriers, and we found systematic higher levels of ␣-actinin-3 in IIx fibers (staining intensity ratio of IIx to IIa: 1.17 Ϯ 0.11). We are not aware of any other study reporting such data. For reasons of improved reliability, the analysis was restricted to RR individuals with at least 10 IIx fibers, and these subjects seemed to be less physically active compared with those individuals with Ͻ10 IIx fibers. Generalization of these results might only apply to moderately active males; however, also in subjects with Ͻ10 IIx fibers, the same trend in increased ␣-actinin-3 staining in IIx was observed. Furthermore, in the overall group (n ϭ 90), h of physical activity per week did not differ between genotype groups, and including h of PA as a covariate did not fundamentally change the results of reported associations between absolute and relative dynamic torques.
Concerning the fiber type specific amount of ␣-actinin-2 protein, we found no differences in staining between the two genotype groups. Therefore, in XX-homozygotes no extra compensation seems to occur concerning the lack of ␣-actinin-3. Literature shows that ␣-actinin-2 and ␣-actinin-3 are structurally similar which makes it likely that ␣-actinin-2 is able to compensate for the lack of ␣-actinin-3 (13), as confirmed in the present study, however, with lower capacities of high velocity contractility.
To conclude, in the present study we expand the existing hypothesis that the R allele enhances high velocity muscle tasks to healthy young men (18 -29 y) . This study is the first to our knowledge to show an association between the ACTN3 (R577X) genotype and the fiber surface and number of fast glycolytic fibers (IIx), in terms of percentage in favor of the RR carriers. Fiber type specific ␣-actinin-3 content measures indicate a 17% higher staining intensity, indicative for a true difference in protein expression in type IIx fibers compared with type IIa fibers.
